{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T22:30:53Z","timestamp":1784673053006,"version":"3.55.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,5,9]],"date-time":"2015-05-09T00:00:00Z","timestamp":1431129600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1208\/s12248-015-9769-x","type":"journal-article","created":{"date-parts":[[2015,5,8]],"date-time":"2015-05-08T17:14:01Z","timestamp":1431105241000},"page":"1135-1143","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Evaluation of the Biological Properties and the Enzymatic Stability of Glycosylated Luteinizing Hormone-Releasing Hormone Analogs"],"prefix":"10.1208","volume":"17","author":[{"given":"Shayli Varasteh","family":"Moradi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pegah","family":"Varamini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istvan","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,9]]},"reference":[{"issue":"1","key":"9769_CR1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1146\/annurev.med.45.1.391","volume":"45","author":"PD Conn","year":"1994","unstructured":"Conn PD, Michael P, Crowley Jr M, William F. Gonadotropin-releasing hormone and its analogs. Annu Rev Med. 1994;45(1):391\u2013405.","journal-title":"Annu Rev Med"},{"issue":"2","key":"9769_CR2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/ncpendmet0399","volume":"3","author":"JB Engel","year":"2007","unstructured":"Engel JB, Schally AV. Drug insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone. Nat Clin Pract Endocrinol Metab. 2007;3(2):157\u201367.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"4","key":"9769_CR3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.yfrne.2003.10.003","volume":"24","author":"P Limonta","year":"2003","unstructured":"Limonta P, Moretti RM, Marelli MM, Motta M. The biology of gonadotropin hormone-releasing hormone: role in the control of tumor growth and progression in humans. Front Neuroendocrinol. 2003;24(4):279\u201395.","journal-title":"Front Neuroendocrinol"},{"issue":"9","key":"9769_CR4","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1023\/A:1018953309913","volume":"10","author":"MF Powell","year":"1993","unstructured":"Powell MF, Stewart T, Otvos L, Urge L, Gaeta FCA, Sette A, et al. Peptide stability in drug development. II. Effect of single amino acid substitution and glycosylation on peptide reactivity in human serum. Pharm Res. 1993;10(9):1268\u201373.","journal-title":"Pharm Res"},{"issue":"4","key":"9769_CR5","doi-asserted-by":"crossref","first-page":"e95024","DOI":"10.1371\/journal.pone.0095024","volume":"9","author":"MP Christie","year":"2014","unstructured":"Christie MP, Simersk\u00e1 P, Jen FE-C, Hussein WM, Rawi MF, Hartley-Tassell LE, et al. A drug delivery strategy: binding enkephalin to asialoglycoprotein receptor by enzymatic galactosylation. PLoS ONE. 2014;9(4):e95024.","journal-title":"PLoS ONE"},{"issue":"10","key":"9769_CR6","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1002\/jps.24120","volume":"103","author":"SV Moradi","year":"2014","unstructured":"Moradi SV, Varamini P, Toth I. The transport and efflux of glycosylated luteinising hormone\u2010releasing hormone analogs in Caco\u20102 cell model: contributions of glucose transporters and efflux systems. J Pharm Sci. 2014;103(10):3217\u201324.","journal-title":"J Pharm Sci"},{"issue":"3","key":"9769_CR7","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0022-3565(24)29218-1","volume":"299","author":"R Egleton","year":"2001","unstructured":"Egleton R, Mitchell S, Huber J, Palian M, Polt R, Davis T. Improved blood\u2013brain barrier penetration and enhanced analgesia of an opioid peptide by glycosylation. J Pharmacol Exp Ther. 2001;299(3):967\u201372.","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"9769_CR8","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.1021\/jm300418d","volume":"55","author":"P Varamini","year":"2012","unstructured":"Varamini P, Mansfeld FM, Blanchfield JT, Wyse BD, Smith MT, Toth I. Synthesis and biological evaluation of an orally active glycosylated endomorphin-1. J Med Chem. 2012;55(12):5859\u201367.","journal-title":"J Med Chem"},{"issue":"16","key":"9769_CR9","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.1021\/jm900473p","volume":"52","author":"T Yamamoto","year":"2009","unstructured":"Yamamoto T, Nair P, Jacobsen NE, Vagner J, Kulkarni V, Davis P, et al. Improving metabolic stability by glycosylation: bifunctional peptide derivatives that are opioid receptor agonists and neurokinin 1 receptor antagonists. J Med Chem. 2009;52(16):5164\u201375.","journal-title":"J Med Chem"},{"issue":"10","key":"9769_CR10","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.peptides.2008.05.018","volume":"29","author":"V Vergote","year":"2008","unstructured":"Vergote V, Van Dorpe S, Peremans K, Burvenich C, De Spiegeleer B. In vitro metabolic stability of obestatin: kinetics and identification of cleavage products. Peptides. 2008;29(10):1740\u20138.","journal-title":"Peptides"},{"issue":"4","key":"9769_CR11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00726-005-0289-3","volume":"30","author":"M Werle","year":"2006","unstructured":"Werle M, Bernkop-Schn\u00fcrch A. Strategies to improve plasma half life time of peptide and protein drugs. Amino Acids. 2006;30(4):351\u201367.","journal-title":"Amino Acids"},{"issue":"2","key":"9769_CR12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1530\/REP-09-0117","volume":"139","author":"K Cleverly","year":"2010","unstructured":"Cleverly K, Wu TJ. Is the metalloendopeptidase EC 3.4. 24.15 (EP24. 15), the enzyme that cleaves luteinizing hormone-releasing hormone (LHRH), an activating enzyme? Reproduction. 2010;139(2):319\u201330.","journal-title":"Reproduction"},{"issue":"1","key":"9769_CR13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0021-9673(95)00948-5","volume":"729","author":"A P\u00e9ter","year":"1996","unstructured":"P\u00e9ter A, Devadder S, Laus G, Tourw\u00e9 D. Liquid chromatography studies on the enzymatic degradation of luteinizing hormone-releasing hormone analogs with off-line identification by mass spectrometry. J Chromatogr A. 1996;729(1):137\u201342.","journal-title":"J Chromatogr A"},{"issue":"1","key":"9769_CR14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0021-9673(94)85177-8","volume":"661","author":"M Brudel","year":"1994","unstructured":"Brudel M, Kertscher U, Berger H, Mehlis B. Liquid chromatographic-mass spectrometric studies on the enzymatic degradation of gonadotropin-releasing hormone. J Chromatogr A. 1994;661(1):55\u201360.","journal-title":"J Chromatogr A"},{"issue":"2","key":"9769_CR15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1210\/edrv.18.2.0295","volume":"18","author":"SC Sealfon","year":"1997","unstructured":"Sealfon SC, Weinstein H, Millar RP. Molecular mechanisms of ligand interaction with the gonadotropin-releasing hormone receptor. Endocr Rev. 1997;18(2):180\u2013205.","journal-title":"Endocr Rev"},{"issue":"1","key":"9769_CR16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijpharm.2009.05.053","volume":"378","author":"YG Bachhav","year":"2009","unstructured":"Bachhav YG, Kalia YN. Stability of triptorelin in the presence of dermis and epidermis. Int J Pharm. 2009;378(1):149\u201351.","journal-title":"Int J Pharm"},{"issue":"2","key":"9769_CR17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.canlet.2005.02.038","volume":"234","author":"S Kraus","year":"2006","unstructured":"Kraus S, Naor Z, Seger R. Gonadotropin-releasing hormone in apoptosis of prostate cancer cells. Cancer Lett. 2006;234(2):109\u201323.","journal-title":"Cancer Lett"},{"issue":"21","key":"9769_CR18","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1016\/S0024-3205(03)00113-9","volume":"72","author":"AV Schally","year":"2003","unstructured":"Schally AV, Nagy A. New approaches to treatment of various cancers based on cytotoxic analogs of LHRH, somatostatin and bombesin. Life Sci. 2003;72(21):2305\u201320.","journal-title":"Life Sci"},{"issue":"23","key":"9769_CR19","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.2174\/092986708785909157","volume":"15","author":"G Mezo","year":"2008","unstructured":"Mezo G, Manea M, Szabo I, Vincze B, Kovacs M. New derivatives of GnRH as potential anticancer therapeutic agents. Curr Med Chem. 2008;15(23):2366\u201379.","journal-title":"Curr Med Chem"},{"issue":"4","key":"9769_CR20","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/j.1939-4640.2000.tb02120.x","volume":"21","author":"L Ravenna","year":"2000","unstructured":"Ravenna L, Salvatori L, Morrone S, Lubrano C, Cardillo M, Sciarra F, et al. Effects of triptorelin, a gonadotropin\u2010releasing hormone agonist, on the human prostatic cell lines PC3 and LNCaP. J Androl. 2000;21(4):549\u201357.","journal-title":"J Androl"},{"issue":"15","key":"9769_CR21","doi-asserted-by":"crossref","first-page":"6331","DOI":"10.1158\/0008-5472.CAN-08-0197","volume":"68","author":"K Morgan","year":"2008","unstructured":"Morgan K, Stewart AJ, Miller N, Mullen P, Muir M, Dodds M, et al. Gonadotropin-releasing hormone receptor levels and cell context affect tumor cell responses to agonist in vitro and in vivo. Cancer Res. 2008;68(15):6331\u201340.","journal-title":"Cancer Res"},{"issue":"15","key":"9769_CR22","first-page":"4091","volume":"54","author":"D Dondi","year":"1994","unstructured":"Dondi D, Limonta P, Moretti RM, Marelli MM, Garattini E, Motta M. Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop. Cancer Res. 1994;54(15):4091\u20135.","journal-title":"Cancer Res"},{"issue":"2","key":"9769_CR23","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0022-5347(05)67947-5","volume":"163","author":"G Halmos","year":"2000","unstructured":"Halmos G, Arencibia JM, Schally AV, Davis R, Bostwick DG. High incidence of receptors for luteinizing hormone-releasing hormone (LHRH) and LHRH receptor gene expression in human prostate cancers. J Urol. 2000;163(2):623\u20139.","journal-title":"J Urol"},{"issue":"3","key":"9769_CR24","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/bip.21521","volume":"96","author":"EV Pappa","year":"2011","unstructured":"Pappa EV, Zompra AA, Spyranti Z, Diamantopoulou Z, Pairas G, Lamari FN, et al. Enzymatic stability, solution structure, and antiproliferative effect on prostate cancer cells of leuprolide and new gonadotropin\u2010releasing hormone peptide analogs. Pept Sci. 2011;96(3):260\u201372.","journal-title":"Pept Sci"},{"issue":"2","key":"9769_CR25","first-page":"393","volume":"15","author":"D Dondi","year":"2006","unstructured":"Dondi D, Festuccia C, Piccolella M, Bologna M, Motta M. GnRH agonists and antagonists decrease the metastatic progression of human prostate cancer cell lines by inhibiting the plasminogen activator system. Oncol Rep. 2006;15(2):393\u2013400.","journal-title":"Oncol Rep"},{"issue":"1","key":"9769_CR26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.yfrne.2007.06.002","volume":"29","author":"RP Millar","year":"2008","unstructured":"Millar RP, Pawson AJ, Morgan K, Rissman EF, Lu Z-L. Diversity of actions of GnRHs mediated by ligand-induced selective signaling. Front Neuroendocrinol. 2008;29(1):17\u201335.","journal-title":"Front Neuroendocrinol"},{"issue":"4","key":"9769_CR27","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1210\/endo-107-4-1144","volume":"107","author":"Z Naor","year":"1980","unstructured":"Naor Z, Clayton RN, Catt KJ. Characterization of gonadotropin-releasing hormone receptors in cultured rat pituitary cells. Endocrinology. 1980;107(4):1144\u201352.","journal-title":"Endocrinology"},{"issue":"6","key":"9769_CR28","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/S0021-9258(19)69722-X","volume":"256","author":"Z Naor","year":"1981","unstructured":"Naor Z, Atlas D, Clayton R, Forman D, Amsterdam A, Catt K. Interaction of fluorescent gonadotropin-releasing hormone with receptors in cultured pituitary cells. J Biol Chem. 1981;256(6):3049\u201352.","journal-title":"J Biol Chem"},{"issue":"1","key":"9769_CR29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0303-7207(83)90203-4","volume":"30","author":"MA Smith","year":"1983","unstructured":"Smith MA, Perrin MH, Vale WW. Desensitization of cultured pituitary cells to gonadotropin-releasing hormone: evidence for a post-receptor mechanism. Mol Cell Endocrinol. 1983;30(1):85\u201396.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"9769_CR30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0303-7207(83)90205-8","volume":"30","author":"G K\u00e9ri","year":"1983","unstructured":"K\u00e9ri G, Nikolics K, Tepl\u00e1n I, Moln\u00e1r J. Desensitization of luteinizing hormone release in cultured pituitary cells by gonadotropin-releasing hormone. Mol Cell Endocrinol. 1983;30(1):109\u201320.","journal-title":"Mol Cell Endocrinol"},{"issue":"14","key":"9769_CR31","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1016\/j.bmc.2013.04.068","volume":"21","author":"SV Moradi","year":"2013","unstructured":"Moradi SV, Mansfeld FM, Toth I. Synthesis and in vitro evaluation of glycosyl derivatives of luteinizing hormone-releasing hormone (LHRH). Bioorg Med Chem. 2013;21(14):4259\u201365.","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"9769_CR32","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/chir.21031","volume":"24","author":"LB Gao","year":"2012","unstructured":"Gao LB, Wang JZ, Yao TW, Zeng S. Study on the metabolic mechanism of chiral inversion of S\u2010Mandelic acid in vitro. Chirality. 2012;24(1):86.","journal-title":"Chirality"},{"issue":"4","key":"9769_CR33","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s00726-012-1231-0","volume":"43","author":"J-F Yao","year":"2012","unstructured":"Yao J-F, Zhou N, Lv Y-J, Zhang R, Liu K-L, Xue M. Metabolic stability of long-acting luteinizing hormone-releasing hormone antagonists. Amino Acids. 2012;43(4):1557\u201366.","journal-title":"Amino Acids"},{"issue":"4","key":"9769_CR34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s13346-012-0082-2","volume":"2","author":"P Tomar","year":"2012","unstructured":"Tomar P, Jain N, Agarwal G, Dixit V. Goserelin loaded nanoparticles inhibit growth and induce apoptosis in human prostate cancer cell lines. Drug Deliv Transl Res. 2012;2(4):265\u201371.","journal-title":"Drug Deliv Transl Res"},{"issue":"13","key":"9769_CR35","doi-asserted-by":"crossref","first-page":"6617","DOI":"10.1016\/j.bmc.2008.05.024","volume":"16","author":"JC Pelletier","year":"2008","unstructured":"Pelletier JC, Chengalvala M, Cottom J, Feingold I, Garrick L, Green D, et al. 2-Phenyl-4-piperazinylbenzimidazoles: orally active inhibitors of the gonadotropin releasing hormone (GnRH) receptor. Bioorg Med Chem. 2008;16(13):6617\u201340.","journal-title":"Bioorg Med Chem"},{"issue":"10","key":"9769_CR36","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.clinthera.2006.10.018","volume":"28","author":"J-P Moreau","year":"2006","unstructured":"Moreau J-P, Delavault P, Blumberg J. Luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer: a review of their discovery, development, and place in therapy. Clin Ther. 2006;28(10):1485\u2013508.","journal-title":"Clin Ther"},{"issue":"1\u20132","key":"9769_CR37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.anireprosci.2005.05.005","volume":"88","author":"AM Padula","year":"2005","unstructured":"Padula AM. GnRH analogs\u2014agonists and antagonists. Anim Reprod Sci. 2005;88(1\u20132):115\u201326.","journal-title":"Anim Reprod Sci"},{"issue":"8","key":"9769_CR38","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.tiv.2011.11.007","volume":"26","author":"S Ferruzza","year":"2012","unstructured":"Ferruzza S, Rossi C, Scarino ML, Sambuy Y. A protocol for in situ enzyme assays to assess the differentiation of human intestinal Caco-2 cells. Toxicol In Vitro. 2012;26(8):1247\u201351.","journal-title":"Toxicol In Vitro"},{"issue":"3","key":"9769_CR39","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1124\/jpet.110.174375","volume":"336","author":"T Katsila","year":"2011","unstructured":"Katsila T, Balafas E, Liapakis G, Limonta P, Montagnani Marelli M, Gkountelias K, et al. Evaluation of a stable gonadotropin-releasing hormone analog in mice for the treatment of endocrine disorders and prostate cancer. J Pharmacol Exp Ther. 2011;336(3):613\u201323.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"9769_CR40","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/mas.20340","volume":"31","author":"T Katsila","year":"2012","unstructured":"Katsila T, Siskos AP, Tamvakopoulos C. Peptide and protein drugs: the study of their metabolism and catabolism by mass spectrometry. Mass Spectrom Rev. 2012;31(1):110\u201333.","journal-title":"Mass Spectrom Rev"},{"key":"9769_CR41","doi-asserted-by":"crossref","unstructured":"Koch Y, Elkabes S, Fridkin M. Degradation of luteinizing hormone-releasing hormone (LHRH) by pituitary plasma membrane and by pituitary cells in culture. Neuroendocrine Molecular Biology: Springer; 1986. pp. 309\u201323.","DOI":"10.1007\/978-1-4684-5131-3_27"},{"issue":"2","key":"9769_CR42","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neulet.2010.10.031","volume":"487","author":"C-Q Gao","year":"2011","unstructured":"Gao C-Q, Fraeyman N, Eertmans F, Dhooge W, Kaufman J-M. Further evaluation of the biological activity of the unique gonadotropin-releasing hormone peptide in the guinea pig brain. Neurosci Lett. 2011;487(2):246\u20139.","journal-title":"Neurosci Lett"},{"issue":"3","key":"9769_CR43","doi-asserted-by":"crossref","first-page":"E317","DOI":"10.1152\/ajpendo.1987.253.3.E317","volume":"253","author":"F Carone","year":"1987","unstructured":"Carone F, Stetler-Stevenson M, May V, LaBarbera A, Flouret G. Differences between in vitro and in vivo degradation of LHRH by rat brain and other organs. Am J Physiol Endocrinol Metab. 1987;253(3):E317\u201321.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"9769_CR44","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3181\/0707-MR-201","volume":"233","author":"K Walters","year":"2008","unstructured":"Walters K, Wegorzewska IN, Chin YP, Parikh MG, Wu T. Luteinizing hormone-releasing hormone I (LHRH-I) and its metabolite in peripheral tissues. Exp Biol Med. 2008;233(2):123.","journal-title":"Exp Biol Med"},{"issue":"2","key":"9769_CR45","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1471-4159.1988.tb01084.x","volume":"51","author":"CJ Molineaux","year":"1988","unstructured":"Molineaux CJ, Lasdun A, Michaud C, Orlowski M. Endopeptidase\u201024.15 is the primary enzyme that degrades luteinizing hormone releasing hormone both in vitro and in vivo. J Neurochem. 1988;51(2):624\u201333.","journal-title":"J Neurochem"},{"issue":"9","key":"9769_CR46","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1023\/A:1011926310666","volume":"15","author":"X Yang","year":"1998","unstructured":"Yang X, Rojanasakul Y, Wang L, Ma JY, Ma JK. Enzymatic degradation of luteinizing hormone releasing hormone (LHRH)\/[D-Ala6]-LHRH in lung pneumocytes. Pharm Res. 1998;15(9):1480\u20134.","journal-title":"Pharm Res"},{"issue":"1","key":"9769_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-4838(98)00248-9","volume":"1429","author":"PM Cummins","year":"1998","unstructured":"Cummins PM, O\u2019Connor B. Pyroglutamyl peptidase: an overview of the three known enzymatic forms. Biochim Biophys Acta. 1998;1429(1):1\u201317.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"9769_CR48","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s002400050054","volume":"26","author":"J Bahk","year":"1998","unstructured":"Bahk J, Hyun J, Lee B, Kim M, Cho G, Choi W. Expression of gonadotropin-releasing hormone (GnRH) and GnRH receptor mRNA in prostate cancer cells and effect of GnRH on the proliferation of prostate cancer cells. Urol Res. 1998;26(4):259\u201364.","journal-title":"Urol Res"},{"issue":"4","key":"9769_CR49","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1517\/13543784.10.4.709","volume":"10","author":"P Limonta","year":"2001","unstructured":"Limonta P, Marelli MM, Moretti RM. LHRH analogs as anticancer agents: pituitary and extrapituitary sites of action. Expert Opin Investig Drugs. 2001;10(4):709\u201320.","journal-title":"Expert Opin Investig Drugs"},{"issue":"3","key":"9769_CR50","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/07357900600629591","volume":"24","author":"E Castell\u00f3n","year":"2006","unstructured":"Castell\u00f3n E, Clementi M, Hitschfeld C, S\u00e1nchez C, Ben\u00edtez D, S\u00e1enz L, et al. Effect of leuprolide and cetrorelix on cell growth, apoptosis, and GnRH receptor expression in primary cell cultures from human prostate carcinoma. Cancer Investig. 2006;24(3):261\u20138.","journal-title":"Cancer Investig"},{"issue":"4","key":"9769_CR51","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1210\/endo-119-4-1510","volume":"119","author":"JA King","year":"1986","unstructured":"King JA, Davidson JS, Millar RP. Desensitization to gonadotropin-releasing hormone in perifused chicken anterior pituitary cells*. Endocrinology. 1986;119(4):1510\u20138.","journal-title":"Endocrinology"},{"issue":"5","key":"9769_CR52","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1507\/endocrj1954.36.739","volume":"36","author":"T Iida","year":"1989","unstructured":"Iida T, Makino T, Seki T, Iizuka R. Mechanism of LH release in cultured rat pituitary cells. Endocrinol Jpn. 1989;36(5):739\u201346.","journal-title":"Endocrinol Jpn"},{"issue":"5","key":"9769_CR53","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1210\/endo-122-5-2211","volume":"122","author":"JE Levine","year":"1988","unstructured":"Levine JE, Duffy MT. Simultaneous measurement of luteinizing hormone (LH)-releasing hormone, LH, and follicle-stimulating hormone release in intact and short-term castrate rats*. Endocrinology. 1988;122(5):2211\u201321.","journal-title":"Endocrinology"},{"issue":"6","key":"9769_CR54","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1210\/endo-98-6-1528","volume":"98","author":"J Drouin","year":"1976","unstructured":"Drouin J, Fernand L. Selective effect of androgens on LH and FSH release in anterior pituitary cells in culture. Endocrinology. 1976;98(6):1528\u201334.","journal-title":"Endocrinology"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-015-9769-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12248-015-9769-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-015-9769-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T21:27:11Z","timestamp":1748381231000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12248-015-9769-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,9]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["9769"],"URL":"https:\/\/doi.org\/10.1208\/s12248-015-9769-x","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,9]]}}}